Latest news with #IMC
Time of India
an hour ago
- Business
- Time of India
IDA to sell flats, plots & shops to boost revenue, targets 261cr
Indore: Indore Development Authority (IDA) is set to generate substantial revenue by selling its vacant plots, flats, and shops, with a target of Rs 261 crore in the coming days. A decision to sell 600 flats, 40 shops, and 24 plots was made during an IDA board meeting, chaired by the Divisional Commissioner Deepak Singh, Collector Asheesh Singh, IMC Commissioner Shivam Verma, and IDA CEO RP Ahirwar among other officials on Friday. The authority will soon issue tenders for these properties, aiming to meet the housing needs of the general public. The IDA has already prepared a comprehensive list of all properties. The board meeting also saw key approvals for infrastructure projects. An agency was finalised to conduct the feasibility survey and prepare tender documents for the 'elevated corridor' extending from Malwa Mill Square to Rasoma Square via Patnipura Square. Additionally, an agency was approved for the feasibility survey and tender proposals for flyovers at Rasoma Square and Ring Road's Robot Square. These approvals follow a previous board meeting where the decision to conduct feasibility studies at all three locations was made, and tenders were subsequently invited. The IDA board also decided to provide Rs 16.98 crore to the Indore Municipal Corporation (IMC). This amount will be used to treat sewage emanating from the sewerage treatment plant in Scheme No. 166. In another significant decision, an industrial plot in Scheme 78 Phase-2 was allotted to the Food Corporation of India (FCI). Furthermore, a plot on the Super Corridor was allocated to the Agricultural Produce Market Committee (Mandi). The board also sanctioned minimum tenders worth Rs 90 crore for various development works and essential facilities across different schemes. These include the construction of a bridge over the Kanh River on MR-12, the building of a 34 lakh-litre capacity water tank in Scheme 151 and 169B, and other approved works under various development plans.
Saba Yemen
5 hours ago
- Health
- Saba Yemen
Civil Society Organizations Condemn Attack on Field Hospital in Al-Zawayda, Gaza
Gaza - Saba: The health sector of the Palestinian Civil Society Organizations Network condemned the attack carried out by a group of bandits and criminals on the American field hospital run by the International Medical Corps (IMC) at dawn today in the Al-Zawayda area in the central Gaza Strip. The attackers robbed the hospital's warehouses and stole large quantities of medical equipment and supplies. The network stated on Friday that "in a serious and unprecedented incident, a group of armed men stormed the field hospital's warehouses and stole large quantities of medical equipment, supplies, medicines, and nutritional supplements for malnourished children." It emphasized that this crime, which is contrary to the traditions and customs of our people, is taking place at a time when our Palestinian people are being subjected to Israeli genocide, including killing, starvation, and deprivation of the necessities of life. The network stated that most hospitals in the Gaza Strip are out of service due to the occupation's bombing and its prevention of the entry of medicines and medical supplies, at a time when the health and humanitarian conditions are deteriorating, threatening the lives of tens of thousands of patients and wounded. The network called on all international parties to pressure the occupation to open the crossings and allow humanitarian aid into the Gaza Strip. Whatsapp Telegram Email Print
Cision Canada
2 days ago
- Business
- Cision Canada
IM Cannabis Announces Plans to Voluntarily Delist from the Canadian Securities Exchange
TORONTO and GLIL YAM, Israel, May 28, 2025 /CNW/ -- IM Cannabis Corp. (the " Company" or " IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announces that it has applied for a voluntary delisting of its common shares (" Shares") from the Canadian Securities Exchange (the " CSE"). The delisting from the CSE will not affect the Company's listing on NASDAQ and its Shares will continue trading on the NASDAQ under the symbol "IMCC". The Company is entertaining potential transactions that, if completed while the Company is listed on the CSE, would require the Company to incur unnecessary burdensome costs, approvals and delay. The Company believes that the trading volume of its Shares on the CSE no longer justifies the expenses, administrative efforts, and regulatory burdens required to maintain a dual listing. The Company also believes that delisting from the CSE will create a central marketplace for its Shares on the Nasdaq and ultimately benefit the long-term liquidity and shareholder value of the Company. All shareholders can continue trading IMC's shares on Nasdaq under the symbol "IMCC". The Company is grateful to the CSE for providing its initial opportunity to access public markets. It is expected, subject to approval from the CSE, that the close of business on Monday, June 2, 2025, will be the final trading day for IMC on the CSE. About IM Cannabis Corp. IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player. The IMC ecosystem operates in Israel through Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms and logistical hubs in Israel that enable the safe delivery and quality control of IMC products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. Forward Looking Information This press release contains certain "forward-looking statements" within the meaning of Canadian securities law. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, identified by words or phrases such as "believes", "anticipates", "expects", "is expected", "scheduled", "estimates", "pending", "intends", "plans", "forecasts", "targets", or "hopes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "will", "should" "might", "will be taken", or "occur" and similar expressions) are not statements of historical fact and may be forward-looking statements. Forward-looking information herein includes, but is not limited to, statements that address activities, events or developments that the Company expects or anticipates will or may occur in the future including the Company's potential delisting from the CSE, the Company's expectation that its Shares will be delisted from the CSE; the Company ceasing to file reports to the CSE after delisting; and the Company's expectation that its S hares will continue trading on the NASDAQ. The Company cautions that forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made, and they involve a number of risks and uncertainties. Consequently, there can be no assurances that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Except to the extent required by applicable securities laws and the policies of the Canadian Securities Exchange, the Company undertakes no obligation to update these forward-looking statements if management's beliefs, estimates or opinions, or other factors, should change. Factors that could cause future results to differ materially from those anticipated in these forward-looking statements include risks associated with the Company's potential delisting from the CSE; the Company ceasing to file reports to the CSE; the Company's ability to relist on the CSE in the future; the timing and receipt of certain approvals from the CSE pertaining to the delisting; and the anticipated benefits associated with delisting. The reader is urged to refer to additional information relating to IMC, including its annual information form, can be located on the SEDAR+ website at and on the EDGAR section of the SEC's website at for a more complete discussion of such risk factors and their potential effects. This list of risk factors should not be construed as exhaustive. The Company does not undertake any obligation to publicly update or revise any forward-looking statements or information contained herein, except as required by applicable laws. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Company Contact: Anna Taranko, Director Investor & Public Relations IM Cannabis Corp. +49 157 80554338 [email protected]
Time of India
3 days ago
- Business
- Time of India
Swachh city to welcome commuters for MP's first Metro train service ride on May 31
Indore: India's cleanest city is poised to enter a new era of urban transportation as Prime Minister Narendra Modi is set to virtually inaugurate the passenger service on Super Priority Corridor of Indore Metro on May 31. With this, Indore will become the first city in Madhya Pradesh to offer Metro train service to commuters. A total of 13 coaches have already arrived at the Metro train depot for operation. The service would be available on over 6 kilometre stretch that forms part of the Yellow Line's Super Priority Corridor. The stretch will include five key stations: Gandhi Nagar Super Corridor 6, Super Corridor 5, Super Corridor 4, and Super Corridor 3. The service will commence from the Gandhi Nagar station. This new corridor is expected to significantly alleviate traffic congestion and reduce pollution while offering commuters a comfortable travel experience. Collector Asheesh Singh visited the Gandhi Nagar station on Tuesday to review preparations for the inauguration ceremony and finalise arrangements. IMC commissioner Shivam Verma, additional commissioner Abhilash Mishra, and Metro officials were also present during the inspection. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Trade Bitcoin & Ethereum – No Wallet Needed! IC Markets Start Now Undo It is noteworthy that the entire Yellow Line of the Indore Metro will span 31.32 km (22.62 km elevated and 8.7 km underground) and will feature 28 stations, promising to make urban travel easier, faster, and more environmentally friendly. The total project cost for the 31.32-kilometre Metro line is approximately Rs 7500 crore, with the initial 6 km corridor alone costing around Rs 1520 crore. Beyond its technical significance, this Super Priority Corridor symbolises Indore's progressive stride towards modernisation.
Yahoo
3 days ago
- Business
- Yahoo
IM Cannabis to Report First Quarter 2025 Financial Results on Thursday, May 15th at 9:00am ET
TORONTO and GLIL YAM, Israel, May 6, 2025 /CNW/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the first quarter 2025 ended March 31, 2025, on Thursday, May 15, 2025, before the market opens. The Company will host a zoom web conference on the same day at 9:00am ET to discuss the results, followed by a question-and-answer session for the investment community. Investors are invited to register by clicking here. All relevant information will be sent upon registration. If you are unable to join us live, a recording of the call will be available on our website at within 24 hours after the call. Link for the zoom call: About IM Cannabis Corp. IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company's focus is to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player. The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. Company Contact: Anna Taranko, Director Investor & Public RelationsIM Cannabis Corp.+49 157 Oren Shuster, CEOIM Cannabis Corp.+972-77-3603504info@ Logo: View original content: SOURCE IM Cannabis Corp. View original content:
